Clinical Trial Update: L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating L19IL2, L19TNF, or L19IL2/TNF for locally advanced basal cell carcinoma, sponsored by Philogen S.p.A.; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• L19IL2 (L19-IL-2)
• L19IL2/TNF
• L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Locally Advanced Basal Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING